文献速递神经肿瘤

基于七个焦亡相关基因的新型风险特征用于胶质瘤预后预测

A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
PubMed 文献 · World Neurosurg · 2021-12-18

本研究探索33个焦亡相关基因在胶质瘤中的表达谱与预后价值,利用LASSO回归在癌症基因组图谱队列构建7基因风险特征,并建立列线图进行外部验证;风险特征可有效预测胶质瘤患者临床结局,功能富集分析提示其可能与侵袭能力和免疫功能相关。

要点

  • 31/33个焦亡相关基因在正常脑组织与胶质瘤组织间表达显著不同。
  • 单因素Cox回归显示24个基因与胶质瘤总生存期显著相关。
  • 基于7基因风险特征和独立预后因素(年龄、WHO分级、IDH状态、特征)的列线图经内外部验证更有效准确。

核心结论

  • 基于7个焦亡相关基因的风险特征能有效预测胶质瘤患者的临床结局。

研究设计与样本

  • 研究探索33个焦亡相关基因在胶质瘤中的表达谱和预后价值,使用LASSO回归在癌症基因组图谱队列构建风险特征,基于独立预后因素构建列线图并进行外部验证,最后进行功能富集分析。

主要发现

  • 大多数焦亡相关基因(31/33)在正常脑组织与胶质瘤组织间表达显著不同。
  • 单因素Cox回归分析发现24个基因与胶质瘤总生存期显著相关。
  • 在癌症基因组图谱训练队列中构建的7基因风险特征通过多数据库验证显示良好的胶质瘤生存预测性能。
  • 基于独立预后因素(年龄、世界卫生组织分级、异柠檬酸脱氢酶状态和风险特征)建立的列线图经内部评估和外部验证证实更有效准确。
  • 功能富集分析提示该风险特征可能与侵袭能力和免疫功能相关。

关键数值与推荐

  • 7基因风险特征用于预测胶质瘤生存。
  • 列线图基于年龄、世界卫生组织分级、异柠檬酸脱氢酶状态和风险特征。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing evidence indicates that pyroptosis is closely linked to the occurrence and progression of cancer. However, the expression and prognostic role of most pyroptosis-related genes in glioma have not been fully elucidated. METHODS: Herein, we explored the expression profiles and prognostic value of 33 pyroptosis-related genes in glioma. LASSO (least absolute shrinkage and selection operator) regression analysis was then used to construct a risk signature to predict glioma outcomes in The Cancer Genome Atlas cohort. Furthermore, we constructed a nomogram based on independent prognostic factors and performed external validation. Finally, functional enrichment analysis was performed to explore the potential biological role of the pyroptosis-related signature in glioma. RESULTS: The expression of most pyroptosis-related genes (31/33) was significantly different between normal brain and glioma tissue. By univariate Cox regression analysis, 24 genes were found to be significantly correlated with glioma overall survival. Subsequently, we constructed a 7-gene risk signature in The Cancer Genome Atlas training cohort, which demonstrated good performance in predicting glioma survival through multidatabase validation. Moreover, a nomogram was established based on independent prognostic factors (age, World Health Organization grade, isocitrate dehydrogenase status, and signature) and confirmed to be more effective and accurate through internal evaluation and external validation. Finally, functional enrichment analyses suggested that the signature might be related to invasion ability and immune function. CONCLUSIONS: The risk signature based on 7 pyroptosis-related genes can effectively predict the clinical outcomes of patients with glioma. Our study provides novel insights for further understanding the association between pyroptosis-related genes and glioma prognosis.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Huang Q, Li J, Mo L, et al. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma. World Neurosurg. 2021. PMID: 34929369. doi:10.1016/j.wneu.2021.12.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。